Loisios-Konstantinidis, Ioannis 
; Hens, Bart ; Mitra, Amitava; Kim, Sarah; Chiann, Chang ; Cristofoletti, Rodrigo
Source: The AAPS Journal. Unidade: IME
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA, REAMOSTRAGEM BOOTSTRAP
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOISIOS-KONSTANTINIDIS, Ioannis et al. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products. The AAPS Journal, v. 22, n. Artigo 113, p. 1-9, 2020Tradução . . Disponível em: https://doi.org/10.1208/s12248-020-00495-4. Acesso em: 06 nov. 2024.APA
Loisios-Konstantinidis, I., Hens, B., Mitra, A., Kim, S., Chiann, C., & Cristofoletti, R. (2020). Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products. The AAPS Journal, 22( Artigo 113), 1-9. doi:10.1208/s12248-020-00495-4NLM
Loisios-Konstantinidis I, Hens B, Mitra A, Kim S, Chiann C, Cristofoletti R. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products [Internet]. The AAPS Journal. 2020 ; 22( Artigo 113): 1-9.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1208/s12248-020-00495-4Vancouver
Loisios-Konstantinidis I, Hens B, Mitra A, Kim S, Chiann C, Cristofoletti R. Using physiologically based pharmacokinetic modeling to assess the risks of failing bioequivalence criteria: a tale of two ibuprofen products [Internet]. The AAPS Journal. 2020 ; 22( Artigo 113): 1-9.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1208/s12248-020-00495-4
